Melanie Rijsbergen (M Rijsbergen)

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Patient Reported

Ejection Fraction

Neoadjuvant Chemotherapy

Top Venues

British journal of clinical pharmacology

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Melanie Rijsbergen, Rianne Rijneveld, Marina Todd, Gary L Feiss, Stijn T P Kouwenhoven, Koen D Quint, Dirk C J G van Alewijk, Maurits N C de Koning, Erica S Klaassen, Jacobus Burggraaf, Robert Rissmann, Mariëtte I E van Poelgeest
Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions. British journal of clinical pharmacology 86 (11) (2020)
Melanie Rijsbergen, Tessa Niemeyer van der Kolk, G Hogendoorn, S Kouwenhoven, C Lemoine, E S Klaassen, M de Koning, S Beck, Jan Nico Bouwes Bavinck, G Feiss, Jacobus Burggraaf, Robert Rissmann
A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts. The British journal of dermatology 180 (5) (2019)
Melanie Rijsbergen, R Rijneveld, M Todd, L Pagan, G Feiss, M N C de Koning, D C J G van Alewijk, E S Klaassen, J Burggraaf, R Rissmann, M I E van Poelgeest
No effect of topical digoxin and furosemide gel for patients with external anogenital warts. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (1) (2019)